- Investing Ideas
- Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Selvita
Market Cap: zł559.8m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł30.50
7D
-4.1%
1Y
6.3%
Ryvu Therapeutics
Market Cap: zł338.0m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł15.24
7D
10.8%
1Y
-50.7%
Molecure
Market Cap: zł123.0m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł5.85
7D
6.4%
1Y
1.0%
Poltreg
Market Cap: zł108.6m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł18.00
7D
-3.7%
1Y
-45.3%